(Q57098373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Clopidogrel discontinuation and platelet reactivity following coronary stenting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Fabio Mangiacapra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Dermot Kenny

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

D Mylotte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A T Tedesco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

P Dicker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D P Foley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

24-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 200

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

The Platelet Activity After Clopidogrel Termination (PACT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Methods for the measurement of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Platelet function analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Reducing intra-individual variation in platelet aggregation: implications for platelet function testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Bioinformatic discovery of novel bioactive peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Platelet function and HIV: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Benefit of clopidogrel for acute coronary syndrome and percutaneous coronary interventions in doubt due to rebound adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Platelet activation and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

Anti-platelet drugs: do they affect megakaryocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04121.X

10.1111/J.1538-7836.2010.04121.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20961396%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference